Servier Selects Oracle to Unify its Clinical Trial Operations
Go back to Servier Selects Oracle to Unify its Clinical Trial Operations| Oracle Corp. (NYSE: ORCL) | Delayed: 126.30 +0.14 (0.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $126.16 | 52 Week High | $42.00 | |||
| Open | $126.06 | 52 Week Low | $33.13 | |||
| Day High | $127.99 | P/E | 53.97 | |||
| Day Low | $123.75 | EPS | $2.34 | |||
| Volume | 11,766,519 | |||||



